Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Divalproex Sodium Extended - Release Tablets, USP (250 mg and 500 mg), a therapeutic equivalent generic version of Depakote® ER (divalproex sodium) Tablet, Extended Release in the US market on August 19, 2013. Dr. Reddy’s ANDA for Divalproex Sodium Extended - Release Tablets, USP was approved by the United States Food & Drug Administration (USFDA).
Help employers find you! Check out all the jobs and post your resume.
